About the journal
ImmunoTargets and Therapy is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 4,320 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 2253-1556
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,320 USD
- Articles in DOAJ
- 332
- Declared review time
- 16 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.dovepress.com/immunotargets-and-therapy-journal
Index listings
- DOAJ · 2016-02-26
- Indexing
- DOAJ
- APC
- 4,320 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
332
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
353
Last recorded publication year
2026
h-index
47
i10-index
143
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2016-02-26
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 86%
- ORCID iDs in current deposits
- 87%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Journal of immunotargets and therapy
- Source type
- journal
- NLM unique ID (PubMed)
- 101606565
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
Show all subjects (50)
- Immune cells in cancer
- Immune cells in cancer
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Immune Response and Inflammation
- Immune Response and Inflammation
- Hepatocellular Carcinoma Treatment and Prognosis
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Peripheral Neuropathies and Disorders
- Psoriasis: Treatment and Pathogenesis
- Psoriasis: Treatment and Pathogenesis
- Peripheral Neuropathies and Disorders
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Immunodeficiency and Autoimmune Disorders
- Lymphoma Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Immunodeficiency and Autoimmune Disorders
- Lymphoma Diagnosis and Treatment
- Dermatology and Skin Diseases
- Chronic Lymphocytic Leukemia Research
- Diabetes and associated disorders
- Dermatology and Skin Diseases
- Chronic Lymphocytic Leukemia Research
- Diabetes and associated disorders
- Single-cell and spatial transcriptomics
- Phagocytosis and Immune Regulation
- Systemic Lupus Erythematosus Research
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cytokine Signaling Pathways and Interactions
- SARS-CoV-2 and COVID-19 Research
- Autoimmune Neurological Disorders and Treatments
- Multiple Sclerosis Research Studies
- Systemic Lupus Erythematosus Research
- Single-cell and spatial transcriptomics
- Multiple Sclerosis Research Studies
- SARS-CoV-2 and COVID-19 Research
- Lung Cancer Research Studies
Keywords (DOAJ)
- immunology
- immune system
- immune-based therapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ